Doctors reviewed data from more than 1,300 patients with a serious type of blood cancer called acute promyelocytic leukemia. The study compared a reduced-intensity treatment plan against standard intensive chemotherapy. The gentler plan used lower doses of certain medicines to start the treatment.
results showed that both groups had very similar success rates. About 92% of patients in the gentler group reached full recovery, which is nearly the same as the 89% seen in the intensive group. Early death rates were also very close between the two groups, suggesting the safer plan is just as effective.
However, the gentler plan did show a clear advantage in keeping patients alive longer without the disease returning. This benefit was seen in the group that received lower doses of medicine at the start. Fewer people in this group experienced a return of their cancer compared to those who received stronger doses.
The study suggests that doctors should consider the gentler approach as the best first choice for high-risk patients. This method helps patients avoid the severe side effects often caused by very strong chemotherapy drugs. Using lower doses might make treatment easier for patients while still giving them a great chance to recover.
